Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:14 AM
NCT ID:
NCT01794520
Group ID:
EG006
Title:
Phase 2 Expansion: Venetoclax 800 mg/Dexamethasone 20 or 40 mg
Description:
The Phase 2 cohort further explored the efficacy of venetoclax in combination with dexamethasone in relapsed or refractory participants with t(11;14) translocation multiple myeloma. Participants received daily venetoclax at a dose of 800 mg (no lead-in period) on Days 1- 21 of each cycle concomitant with weekly dexamethasone at a dose of 40 mg (20 mg for those aged ≥ 75 years).
Deaths Number Affected:
22
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
31
Other Number Affected:
27
Other Number At Risk:
31
Study:
NCT01794520
Results Section:
NCT01794520
Adverse Events Module:
NCT01794520